GILEAD SCIENCES INC revenue for the last year amounted to 23.91 T CLP, the most of which — 23.91 T CLP — came from its highest performing source at the moment, Innovative Medicines, the year earlier bringing 23.24 T CLP. The greatest contribution to the revenue figure was made by United States — last year it brought GILEAD SCIENCES INC 17.14 T CLP, and the year before that — 16.09 T CLP.